Revenio Group Oyj (LON:0KFH)
23.83
+0.68 (2.92%)
At close: Oct 13, 2025
Revenio Group Oyj Revenue
Revenio Group Oyj had revenue of 26.50M EUR in the quarter ending June 30, 2025, with 3.92% growth. This brings the company's revenue in the last twelve months to 107.22M, up 6.70% year-over-year. In the year 2024, Revenio Group Oyj had annual revenue of 103.82M with 7.27% growth.
Revenue (ttm)
107.22M EUR
Revenue Growth
+6.70%
P/S Ratio
6.28
Revenue / Employee
444.90K EUR
Employees
241
Market Cap
576.82M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103.82M | 7.04M | 7.27% |
| Dec 31, 2023 | 96.79M | -445.00K | -0.46% |
| Dec 31, 2022 | 97.23M | 17.88M | 22.53% |
| Dec 31, 2021 | 79.36M | 18.04M | 29.43% |
| Dec 31, 2020 | 61.31M | 11.60M | 23.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |